"But there's been a missing link, which turns out to be genetic
factors," she tells WebMD.
African-American men are more likely to develop prostate
cancer than white men, and over two times more likely to die from the
disease, according to the American Cancer Society.
To determine what role genetics plays, Wallace and colleagues compared
prostate tumors that had been removed from 33 African-Americans and 36 white
men. Standard gene-chip technology was used to examine the samples.
Results showed that the activity of 162 genes was different between the two
Wallace says that genes that suppress the immune system were more likely to
be overactive in African-American men. A weakened immune system doesn't
recognize tumor cells as foreign invaders that need to be quashed. This allows
cancer cells to grow and spread.
Other genes that were overexpressed in African-Americans are involved in the
production of interferon, a substance that helps combat infection with
That finding raises the intriguing possibility that African-American men are
being infected with an unidentified prostate-cancer-causing virus, Wallace
The research was presented at the annual meeting of the American Association
for Cancer Research.
Genes Play Role in Deadly Breast Tumors
Genetic differences may also help explain a well-known paradox in cancer
care: African-American women have a lower risk of developing breast cancer than whites but a
higher risk of dying from it.
African-American women are 36% more likely to die from breast cancer than
white women, according to the American Cancer Society.
African-American women are more likely to develop large and aggressive
tumors that are notoriously difficult to treat, says Lori Field, PhD, of the
Windber Research Institute in Windber, Pa.
Field and colleagues examined breast tumor samples from 26 African-Americans
and 26 whites.
All the women were being treated at the Walter Reed Army Medical Center in
Washington, D.C., because they or a family member were in the military. That's
important because it minimizes the chance the unequal access to care would
affect the results.